NR6A1 and breast carcinoma: NR6A1 is very lowly expressed in the mammary glands but highly expressed in some types of breast cancer[20,21]; the ability of NR6A1 to interact with other types of co-repressors such as ERR, N-CoR, and SMRT was demonstrated in various experimental models[22,23].